Peptide

BRIEF: Medtide rises in Hong Kong trading debut

Peptide-focused contract research, development and manufacturing organization (CRDMO) Medtide Inc. (3880.HK) opened 4% higher in its Hong Kong trading debut on Monday, and closed up 3.76% at HK$31.75 by the…
3880.HK

Recent Articles

RELATED ARTICLES

  1. Medtide launches IPO
    ​​Medtide launches IPO to bulk up its weight-loss business
    3880.HK
  2. BRIEF:  Zhou Liu Fu rises in Hong Kong trading debut
    6168.HK
  3. BRIEF: Zenergy rises 2% in Hong Kong trading debut
    3677.HK
  4. BRIEF: Conch Materials slumps, ContiOcean rises in two Hong Kong trading debuts
    2613.HK 2560.HK
  5. BRIEF: Mixue surges on Hong Kong trading debut
    2097.HK
  6. BRIEF: Drinda New Energy rises in Hong Kong trading debut
    2865.HK 002865.SHE
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva